首页> 美国卫生研究院文献>Oncotarget >Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods
【2h】

Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods

机译:不同前列腺活检方法对中国汉族人群前列腺癌检出率(PCDR)的特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We analyzed the improvement of prostate cancer detection rate (PCDR) in Chinese Han population and summarized the characteristics of prostate cancer (PCa) with the advancement of prostate biopsy technologies. From March 1999 to March 2015, 3762 patients underwent the systematic 6-, 8- or 13-core biopsy, guided by finger or transrectal ultrasound (TRUS) at our center. The PCDR under different PSA intervals and different biopsy methods were analyzed. The trends of PSA level, age and Gleason score of PCa patients were summarized. The PCDR of finger-guided 6- and 8-core biopsies were 30.8% (340/1103) and 36.7% (147/401) respectively. In 2258 patients with TRUS-guided 13-core biopsies, 992 (43.9%) were diagnosed as PCa, higher than that with finger-guided biopsies (43.9% vs. 32.4%, p < 0.001). The PCDR of prostate peripheral zone was higher than that of medial zone (37.5% vs. 31.4%, p < 0.001). Interestingly, the PCDR of extra 13th core was higher than the mean positive rate of other 12 cores (70.7% vs. 56.0%, p < 0.001). The systematic 13-core prostate biopsy guided by TRUS is safe, effective, and economic for PCa diagnosis in developing countries like China. The extra 13th core biopsy is beneficial to increase the PCDR.
机译:我们分析了中国汉族人群前列腺癌检出率(PCDR)的提高,并总结了随着前列腺活检技术的发展而出现的前列腺癌(PCa)的特征。从1999年3月到2015年3月,在我们中心对3762例患者进行了手指,经直肠超声(TRUS)引导的系统性6、8或13芯活检。分析了不同PSA间隔和不同活检方法下的PCDR。总结了PCa患者的PSA水平,年龄和Gleason评分趋势。手指引导的6芯和8芯活检的PCDR分别为30.8%(340/1103)和36.7%(147/401)。在2258例TRUS引导的13核心活检患者中,诊断为PCa的为992(43.9%),高于手指引导的活检(43.9%对32.4%,p <0.001)。前列腺周围区的PCDR高于内侧区的PCDR(37.5%比31.4%,p <0.001)。有趣的是,第13个核心的PCDR高于其他12个核心的平均阳性率(70.7%对56.0%,p <0.001)。在像中国这样的发展中国家,以TRUS指导的系统性13核前列腺活检对PCa诊断是安全,有效和经济的。额外的第13核心活检有助于增加PCDR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号